Assessment of animal models for MS and demyelinating disease in the design of rational therapy

被引：207

作者：

Steinman, L ^{[1
]}

机构：

[1] Stanford Univ, Beckman Ctr Mol Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA

来源：

NEURON | 1999年 / 24卷 / 03期

关键词：

D O I：

10.1016/S0896-6273(00)81107-1

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

[No abstract available]

引用

页码：511 / 514

页数：4

共 17 条

[1] The development of Cop 1 (Copaxone(R)), an innovative drug for the treatment of multiple sclerosis: Personal reflections [J].

Arnon, R .

IMMUNOLOGY LETTERS, 1996, 50 (1-2) :1-15

[2] The immunobiology of multiple sclerosis: An autoimmune disease of the central nervous system [J].

Conlon, P ;

Oksenberg, JR ;

Zhang, JQ ;

Steinman, L .

NEUROBIOLOGY OF DISEASE, 1999, 6 (03) :149-166

[3] Local delivery of TNF by retrovirus-transduced T lymphocytes exacerbates experimental autoimmune encephalomyelitis [J].

Dal Canto, RA ;

Shaw, MK ;

Nolan, GP ;

Steinman, L ;

Fathman, CG .

CLINICAL IMMUNOLOGY, 1999, 90 (01) :10-14

[4] Identification of autoantibodies associated with myelin damage in multiple sclerosis [J].

Genain, CP ;

Cannella, B ;

Hauser, SL ;

Raine, CS .

NATURE MEDICINE, 1999, 5 (02) :170-175

[5]

KABAT EA, 1947, J EXP MED, V85, P117, DOI 10.1084/jem.85.1.117

[6] Interferon-gamma confers resistance to experimental allergic encephalomyelitis [J].

Krakowski, M ;

Owens, T .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (07) :1641-1646

[7] Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease [J].

Lafaille, JJ ;

VandeKeere, F ;

Hsu, AL ;

Baron, JL ;

Haas, W ;

Raine, CS ;

Tonegawa, S .

JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (02) :307-312

[8] TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination [J].

Liu, JL ;

Marino, MW ;

Wong, G ;

Grail, D ;

Dunn, A ;

Bettadapura, J ;

Slavin, AJ ;

Old, L ;

Bernard, CCA .

NATURE MEDICINE, 1998, 4 (01) :78-83

[9] TREATMENT OF MULTIPLE-SCLEROSIS WITH GAMMA-INTERFERON - EXACERBATIONS ASSOCIATED WITH ACTIVATION OF THE IMMUNE-SYSTEM [J].

PANITCH, HS ;

HIRSCH, RL ;

SCHINDLER, J ;

JOHNSON, KP .

NEUROLOGY, 1987, 37 (07) :1097-1102

[10]

RAINE CS, 1989, LAB INVEST, V60, P714

← 1 2 →